China Medical Technologies to Hold its Annual General Meeting on November 16, 2009
28 October 2009 - 10:00PM
PR Newswire (US)
BEIJING, Oct. 28 /PRNewswire-Asia-FirstCall/ -- China Medical
Technologies, Inc. (the "Company") (NASDAQ:CMED), a leading
China-based medical device company that develops, manufactures and
markets advanced in-vitro diagnostic products, today announced that
the Company will hold its annual general meeting of shareholders at
the Company's office at 24 Yong Chang North Road, Beijing
Economic-Technological Development Area, Beijing 100176, the
People's Republic of China on November 16, 2009 at 9:00 a.m., local
time. Holders of record of ordinary shares of the Company at the
close of business on October 2, 2009 are entitled to vote at the
annual general meeting or any adjournment thereof in person or by
proxy. Holders of the Company's American Depositary Shares ("ADSs")
who wish to exercise their voting rights for the underlying
ordinary shares should follow the instructions that they receive
from the depositary of the Company's ADS program, Citibank, N.A.
The notice of the annual general meeting, form of proxy card and
the proxy statement that sets forth the proposal to be submitted
for shareholders' approval at the meeting are available on the
Company's Investor Relations website at
http://ir.chinameditech.com/ . The Company has filed its annual
report, including its audited consolidated financial statements for
the fiscal year ended March 31, 2009, on Form 20-F with the U.S.
Securities and Exchange Commission (the "SEC"). The Company's
annual report on Form 20-F can be accessed on the above-mentioned
website of the Company, as well as on the SEC's website at
http://www.sec.gov/ . Shareholders and ADS holders can request a
hard copy of the Company's annual report, free of charge, by email
to . About China Medical Technologies, Inc. China Medical
Technologies is a leading China-based medical device company that
develops, manufactures and markets advanced in-vitro diagnostic
(IVD) products using Enhanced Chemiluminescence (ECLIA) technology,
Fluorescent in situ Hybridization (FISH) technology and Surface
Plasmon Resonance (SPR) technology to detect and monitor various
diseases and disorders. For more information, please visit
http://www.chinameditech.com/ . For more information, please
contact: Winnie Yam Tel: +852-2511-9808 Email: DATASOURCE: China
Medical Technologies, Inc. CONTACT: Winnie Yam, +852-2511-9808, Web
site: http://www.chinameditech.com/ http://ir.chinameditech.com/
Copyright
China Medical (NASDAQ:CMED)
Historical Stock Chart
From Jun 2024 to Jul 2024
China Medical (NASDAQ:CMED)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about China Medical Technologies ADS, Each Representing 10 Ordinary Shares (MM) (NASDAQ): 0 recent articles
More China Medical Technologies - Ads (MM) News Articles